Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16536922 | 0.87 | TSHR (0.36) | TSHRHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL134911 | 0.86 | TSHR (0.35) | TSHRHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL18918481 | 0.86 | TSHR (0.37) | TSHRHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL109906 | 0.84 | TSHR (0.36) | TSHRHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL3832655 | 0.84 | TSHR (0.36) | TSHRHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL16537303 | 0.84 | TSHR (0.44) | TSHRHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL16536935 | 0.83 | TSHR (0.33) | TSHRHPGD | |
| SCHEMBL374775 | 0.83 | TSHR (0.38) | TSHRHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL5838258 | 0.82 | TSHR (0.39) | TSHRHPGDALDH1A1TP53CYP3A4 | |
| SCHEMBL1067079 | 0.81 | TSHR (0.34) | TSHRHPGDALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725470-A1 | CURABLE DENTAL COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2026-04-15 | — | — | EP | disclosed |
| CN-119584936-A | Curable composition for producing transparent orthodontic accessories | 舒万诺知识产权公司 | 2025-03-07 | — | — | CN | disclosed |
| US-20250032366-A1 | DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2025-01-30 | — | — | US | disclosed |
| US-20250009607-A1 | DENTAL COMPOSITION AND METHOD OF PRODUCTION THEREOF, AND SURFACE-TREATED FILLER FOR DENTAL USE | KURARAY NORITAKE DENTAL INC. (JP) | 2025-01-09 | — | — | US | disclosed |
| EP-4464301-A1 | DENTAL COMPOSITION, METHOD FOR MANUFACTURING SAME, AND DENTAL SURFACE-TREATED FILLER | Kuraray Noritake Dental Inc. (JP) | 2024-11-20 | — | — | EP | disclosed |
| EP-4445891-A1 | DENTAL CURABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2024-10-16 | — | — | EP | disclosed |
| EP-3507011-B1 | SHAPED GEL ARTICLES AND SINTERED ARTICLES PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-06-26 | — | — | EP | disclosed |
| US-11884550-B2 | Shaped gel articles and sintered articles prepared therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-01-30 | — | — | US | disclosed |
| CN-117377722-A | Rubber composition and tire | 株式会社普利司通 | 2024-01-09 | — | — | CN | disclosed |
| CN-117136204-A | Polysiloxane resin and use thereof | 株式会社钟化 | 2023-11-28 | — | — | CN | disclosed |
| US-7834120-B2 | Monofunctional monomer having cage oligosiloxane structure and method of making | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-11-16 | — | — | US | disclosed |
| EP-1645560-B1 | Monofunctional monomer having cage oligosiloxane structure and method of making | SHINETSU CHEMICAL CO (JP) | 2008-05-28 | — | — | EP | disclosed |
| EP-1645560-A1 | Monofunctional monomer having cage oligosiloxane structure and method of making | Shin-Etsu Chemical Co., Ltd. (JP) | 2006-04-12 | — | — | EP | disclosed |
| US-20060074213-A1 | Monofunctional monomer having cage oligosiloxane structure and method of making | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-04-06 | — | — | US | disclosed |
| EP-1323779-A1 | Foamed polyolefin sheets with improved property spectrum | Borealis GmbH (AT) | 2003-07-02 | — | — | EP | disclosed |
| EP-0695783-B1 | Low solvent content type-resin composition, coating composition containing such resin composition and process for coating such coating composition | MAZDA MOTOR (JP) | 2000-02-02 | — | — | EP | disclosed |
| US-5738976-A | HEAT RESISTANT, STORAGE STABLE POLYSILSESQUIOXANE MIXED WITH PHOTOSENSITIZER; PHOTORESISTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1998-04-14 | — | — | US | disclosed |
| US-5650475-A | VINYL POLYMERS WITH BLOCKED CARBOXY, SILANOL, EPOXY, HYDROLYZED SILYL AND ACID ANHYDRIDES IN SOLVENTS | MAZDA MOTOR CORPORATION (JP) | 1997-07-22 | — | — | US | disclosed |
| EP-0695783-A2 | Low solvent content type-resin composition, coating composition containing such resin composition and process for coating such coating composition | Mazda Motor Corporation (JP) | 1996-02-07 | — | — | EP | disclosed |
| EP-0688841-A2 | Low solvent content type-resin composition, coating composition containing such resin composition and process for coating such coating composition | MAZDA MOTOR CORPORATION (JP) | 1995-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032366-A1 | DENTAL CURABLE COMPOSITION | H1-0, COL1A1, CHAF1B | TSHR 4352/4885HPGD 2520/4885ALDH1A1 1530/4885 |
| US-20250009607-A1 | DENTAL COMPOSITION AND METHOD OF PRODUCTION THEREOF, AND SURFACE-TREATED FILLER FOR DENTAL USE | CAD, SEM1, CAPZA1 | TSHR 3083/4885HPGD 1522/4885ALDH1A1 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.